Skip to main content
Log in

Participation Hospital’s Pharmacist in the Voluntary Reporting Adverse Drug Reactions and Costs Involved in their Management

  • Abstract
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. De Abajo F, Montero D. Farmacovigilancia I: origen, fines y estrategias. Agencia Española del Medicamento. División de farmacoepidemiologia y farmacovigilancia. Santa Cruz de la Sierra 2000.

  2. The Uppsala Monitoring Centre. The importance of pharmacovigilance. Safety Monitoring of Medicinal Products, OMS 2002.

  3. Instituto Catalán de Farmacologia. Efectos indeseados: un coste no sólo económico. Butlleti groc 1999; 12(1): 4–6

    Google Scholar 

  4. Ruiz Caldes MJ, Magraner Gil J, Tordera Baviera M, et al. Farmacovigilancia: Importancia del Farmaceutico de Hospital. Servicio de Farmacia. Hospital Clinico Universitario de Valencia, España 2000

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kyonen, M., Caro, C., Folatre, L. et al. Participation Hospital’s Pharmacist in the Voluntary Reporting Adverse Drug Reactions and Costs Involved in their Management. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00011

Keywords

Navigation